Physician profile
Rachele Roberts
NPI 1558833863
$18,924.11
in general payments reported to CMS, 2019-2025
9 companies · $4,189 in 2025
The $4,189 reported for 2025 was more than what 99% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.59 · 2022: $4,752 · 2023: $7,089 · 2024: $2,869 · 2025: $4,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,388 · Travel and Lodging: $5,757 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,388.40 |
| Travel and Lodging | $5,756.89 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $6,332.56 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Medtronic, INC. | $4,993.45 | 2022-2025 | Corevalve Evolut R, Symplicity G3 |
| Abbott Laboratories | $4,642.25 | 2022-2025 | Mitraclip, Triclip, Amplatzer Piccolo |
| Boston Scientific Corporation | $2,457.07 | 2022-2025 | Watchman Access System, Watchman Flx, Watchman |
| Abiomed | $331.72 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $58.90 | 2024 | Uptravi, Opsumit |
| Philips North America LLC | $56.01 | 2025 | Lm Undivided |
| Lantheus Medical Imaging, INC. | $29.90 | 2023 | Definity |
| Octapharma USA, INC. | $22.25 | 2025 | Fibryga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachele Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.